Literature DB >> 17697005

Survival of Mycobacterium ulcerans at 37 degrees C.

M Eddyani1, F Portaels.   

Abstract

Bone infection and metastatic spread in cases of Buruli ulcer imply that Mycobacterium ulcerans is able to survive and multiply at 37 degrees C. This study investigated the survival at 37 degrees C of M. ulcerans isolates from diverse geographical and clinical sources. Although the viability of all isolates decreased after a few days at 37 degrees C, viable bacilli remained after 13 days at 37 degrees C in most instances. African isolates of M. ulcerans were more thermotolerant than isolates from temperate regions. Isolates from skin and bone lesions of the same patients showed no difference in thermotolerance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697005     DOI: 10.1111/j.1469-0691.2007.01791.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  10 in total

Review 1.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

2.  In Vitro Assessment of Drug Activity Against Mycobacterium ulcerans.

Authors:  Oliver D Komm; Deepak V Almeida; Paul J Converse; Eric L Nuermberger
Journal:  Methods Mol Biol       Date:  2022

3.  Screening of antifungal azole drugs and agrochemicals with an adapted alamarBlue-based assay demonstrates antibacterial activity of croconazole against Mycobacterium ulcerans.

Authors:  Nicole Scherr; Katharina Röltgen; Matthias Witschel; Gerd Pluschke
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

Review 4.  Ecology and transmission of Buruli ulcer disease: a systematic review.

Authors:  Richard W Merritt; Edward D Walker; Pamela L C Small; John R Wallace; Paul D R Johnson; M Eric Benbow; Daniel A Boakye
Journal:  PLoS Negl Trop Dis       Date:  2010-12-14

5.  Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?

Authors:  Marie-Thérèse Ruf; Annick Chauty; Ambroise Adeye; Marie-Françoise Ardant; Hugues Koussemou; Roch Christian Johnson; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2011-08-02

6.  First cultivation and characterization of Mycobacterium ulcerans from the environment.

Authors:  Françoise Portaels; Wayne M Meyers; Anthony Ablordey; António G Castro; Karim Chemlal; Pim de Rijk; Pierre Elsen; Krista Fissette; Alexandra G Fraga; Richard Lee; Engy Mahrous; Pamela L C Small; Pieter Stragier; Egídio Torrado; Anita Van Aerde; Manuel T Silva; Jorge Pedrosa
Journal:  PLoS Negl Trop Dis       Date:  2008-03-26

7.  A protocol for culturing environmental strains of the Buruli ulcer agent, Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Arup Panda; Michel Drancourt
Journal:  Sci Rep       Date:  2018-04-30       Impact factor: 4.379

8.  Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.

Authors:  Hui Hong; Emmanuelle Coutanceau; Marion Leclerc; Laxmee Caleechurn; Peter F Leadlay; Caroline Demangel
Journal:  PLoS Negl Trop Dis       Date:  2008-10-22

9.  Phase change material for thermotherapy of Buruli ulcer: a prospective observational single centre proof-of-principle trial.

Authors:  Thomas Junghanss; Alphonse Um Boock; Moritz Vogel; Daniela Schuette; Helmut Weinlaeder; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2009-02-17

10.  Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis.

Authors:  Marie-Thérèse Ruf; Miriam Bolz; Moritz Vogel; Pierre F Bayi; Martin W Bratschi; Ghislain Emmanuel Sopho; Dorothy Yeboah-Manu; Alphonse Um Boock; Thomas Junghanss; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2016-06-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.